| Year |
Citation |
Score |
| 2023 |
Diep CH, Mauro LJ, Lange CA. Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for developing breast cancer. Steroids. 109329. PMID 37884178 DOI: 10.1016/j.steroids.2023.109329 |
0.455 |
|
| 2023 |
Mauro LJ, Spartz A, Austin JR, Lange CA. Re-evaluating the role of progesterone in ovarian cancer: is progesterone always protective? Endocrine Reviews. PMID 37261958 DOI: 10.1210/endrev/bnad018 |
0.48 |
|
| 2023 |
Dwyer AR, Perez Kerkvliet C, Truong TH, Hagen KM, Krutilina RI, Parke DN, Oakley RH, Liddle C, Cidlowski JA, Seagroves TN, Lange CA. Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4. Endocrinology. 164. PMID 37224504 DOI: 10.1210/endocr/bqad083 |
0.578 |
|
| 2023 |
Tarullo SE, He Y, Daughters C, Knutson TP, Henzler CM, Price MA, Shanley R, Witschen P, Tolg C, Kaspar RE, Hallstrom C, Gittsovich L, Sulciner ML, Zhang X, Forster CL, ... Lange CA, et al. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology. PMID 37186300 DOI: 10.1002/path.6082 |
0.786 |
|
| 2021 |
Mauvais-Jarvis F, Lange CA, Levin ER. Membrane-initiated estrogen, androgen and progesterone receptor signaling in health and disease. Endocrine Reviews. PMID 34791092 DOI: 10.1210/endrev/bnab041 |
0.317 |
|
| 2021 |
Kerkvliet CP, Truong TH, Ostrander JH, Lange CA. Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment. Essays in Biochemistry. PMID 34132331 DOI: 10.1042/EBC20200165 |
0.607 |
|
| 2021 |
Truong TH, Benner EA, Hagen KM, Temiz NA, Kerkvliet CP, Wang Y, Cortes-Sanchez E, Yang CH, Trousdell MC, Pengo T, Guillen KP, Welm BE, Dos Santos CO, Telang S, Lange CA, et al. PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER breast cancer. Oncogene. PMID 34103681 DOI: 10.1038/s41388-021-01871-w |
0.52 |
|
| 2021 |
Werner LR, Gibson KA, Goodman ML, Helm DE, Walter KR, Holloran SM, Trinca GM, Hastings RC, Yang HH, Hu Y, Wei J, Lei G, Yang XY, Madan R, Molinolo AA, ... ... Lange CA, et al. Progesterone promotes immunomodulation and tumor development in the murine mammary gland. Journal For Immunotherapy of Cancer. 9. PMID 33958486 DOI: 10.1136/jitc-2020-001710 |
0.453 |
|
| 2021 |
Mauro LJ, Seibel MI, Diep CH, Spartz A, Perez Kerkvliet C, Singhal H, Swisher EM, Schwartz LE, Drapkin R, Saini S, Sesay F, Litovchick L, Lange CA. Progesterone Receptors Promote Quiescence & Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models. The Journal of Clinical Endocrinology and Metabolism. PMID 33755733 DOI: 10.1210/clinem/dgab195 |
0.417 |
|
| 2021 |
Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar C, Rui H, Yee D, Lange C. Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology. PMID 33735382 DOI: 10.1210/endocr/bqab060 |
0.484 |
|
| 2020 |
Dwyer AR, Perez Kerkvliet C, Krutilina RI, Playa HC, Parke DN, Thomas WA, Smeester BA, Moriarity BS, Seagroves TN, Lange CA. Breast tumor kinase (Brk/PTK6) mediates advanced cancer phenotypes via SH2-domain dependent activation of RhoA and aryl hydrocarbon receptor (AhR) signaling. Molecular Cancer Research : McR. PMID 33172975 DOI: 10.1158/1541-7786.MCR-20-0295 |
0.518 |
|
| 2020 |
Dwyer AR, Truong TH, Kerkvliet CP, Paul KV, Kabos P, Sartorius CA, Lange CA. Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer. British Journal of Cancer. PMID 33144693 DOI: 10.1038/s41416-020-01094-y |
0.478 |
|
| 2020 |
Perez Kerkvliet C, Dwyer AR, Diep CH, Oakley RH, Liddle C, Cidlowski JA, Lange CA. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer. Breast Cancer Research : Bcr. 22: 39. PMID 32357907 DOI: 10.1186/S13058-020-01277-8 |
0.635 |
|
| 2020 |
Dwyer AR, Truong TH, Ostrander JH, Lange CA. Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide. Journal of Molecular Endocrinology. PMID 32209723 DOI: 10.1530/Jme-19-0274 |
0.631 |
|
| 2020 |
Sathyamoorthy N, Lange CA. Progesterone and Breast Cancer: an NCI Workshop Report. Hormones & Cancer. PMID 32016820 DOI: 10.1007/S12672-020-00379-1 |
0.546 |
|
| 2020 |
Dwyer AR, Kerkvliet CJP, Krutilina R, Playa H, Park D, Thomas W, Smeester B, Seagroves TN, Lange CA. SAT-133 Breast Tumor Kinase (Brk/PTK6) Mediates Triple Negative Breast Cancer Cell Migration and Taxol Resistance via SH2 Domain-Dependent Activation of RhoA and AhR Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.1750 |
0.636 |
|
| 2020 |
Truong TH, Benner E, Ostrander JH, Lange CA. OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast Cancer Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.1307 |
0.611 |
|
| 2020 |
Guo Z, Lei J, Wu S, Molina-Vega J, Cervantes P, Rom'Mand AR, Mijangos DCC, Falck JR, Lange C, Wang J, Potter DA. Abstract 4372: Metformin inhibits nuclear localization of estrogen receptor alpha in breast cancer cells, in part, by inhibition of CYP-mediated epoxyeicosatrienoic acid (EET) biosynthesis Epidemiology. 80: 4372-4372. DOI: 10.1158/1538-7445.Am2020-4372 |
0.584 |
|
| 2019 |
Perez Kerkvliet C, Dwyer A, Regan Anderson T, Oram M, Smeester B, Cidlowski J, Seagroves T, Lange C. SUN-008 The Glucocorticoid Receptor Is Essential For TGFβ and p38 MAPK Mediated Cancer Phenotypes in Triple Negative Breast Cancer Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sun-008 |
0.603 |
|
| 2019 |
Dwyer A, Perez Kerkvliet C, Lange C. SUN-007 Discovery of Novel Signaling Pathways Downstream of PTK6 in TNBC Models Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sun-007 |
0.327 |
|
| 2019 |
Seibel M, Spartz A, Drapkin R, Schwartz L, Mauro L, Lange C. SUN-004 Unique Cell Fates and Metastatic Phenotypes Are Activated by Progesterone Receptor (PR) Isoform-specific Gene Expression in Fallopian Tube Models of HGSC Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sun-004 |
0.483 |
|
| 2019 |
Ostrander J, Truong T, Benner E, Lange C. OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Or34-1 |
0.595 |
|
| 2019 |
Truong T, Dwyer A, Diep C, Lange C. OR26-1 Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem-Like and Proliferative Breast Cancer Cell Fates Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Or26-1 |
0.618 |
|
| 2019 |
Truong T, Dwyer A, Diep C, Lange C. Abstract P5-05-06: Progesterone receptor (PR) isoform-specific expansion of breast cancer stem-like cells occurs through a phospho-PR/FOXO1 driven signaling axis Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-05-06 |
0.677 |
|
| 2019 |
Guo Z, Wu S, Molina-Vega J, Castillo R, Barrera J, Johnson V, Lange C, Potter D. Abstract LB-023: CYP monooxygenases regulate nuclear localization of ERá and mTORC1 component RagC in ER+HER2- breast cancer cells Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-023 |
0.618 |
|
| 2018 |
Truong TH, Lange CA, Ostrander JH. Targeting steroid receptor co-activators to inhibit breast cancer stem cells. Oncoscience. 5: 281-282. PMID 30652114 DOI: 10.18632/oncoscience.469 |
0.509 |
|
| 2018 |
Truong TH, Dwyer AR, Diep CH, Hu H, Hagen KM, Lange CA. Phosphorylated progesterone receptor isoforms mediate opposing stem cell and proliferative breast cancer cell fates. Endocrinology. PMID 30597041 DOI: 10.1210/En.2018-00990 |
0.661 |
|
| 2018 |
Truong TH, Lange CA. "Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers". Endocrinology. PMID 30307542 DOI: 10.1210/En.2018-00831 |
0.6 |
|
| 2018 |
Leontovich AA, Jalalirad M, Salisbury JL, Mills L, Haddox C, Schroeder M, Tuma A, Guicciardi ME, Zammataro L, Gambino MW, Amato A, Di Leonardo A, McCubrey J, Lange CA, Liu M, et al. NOTCH3 expression is linked to breast cancer seeding and distant metastasis. Breast Cancer Research : Bcr. 20: 105. PMID 30180881 DOI: 10.1186/S13058-018-1020-0 |
0.519 |
|
| 2018 |
Regan Anderson TM, Ma S, Perez Kerkvliet C, Peng Y, Helle TM, Krutilina RI, Raj GV, Cidlowski JA, Ostrander JH, Schwertfeger KL, Seagroves TN, Lange CA. Taxol Induces Brk-dependent Pro-survival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Molecular Cancer Research : McR. PMID 29991529 DOI: 10.1158/1541-7786.Mcr-18-0410 |
0.636 |
|
| 2018 |
Truong TH, Hu H, Temiz NA, Hagen K, Girard BJ, Brady NJ, Schwertfeger KL, Lange CA, Ostrander JH. Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models are Promoted by PELP1/AIB1 Complexes. Molecular Cancer Research : McR. PMID 29348189 DOI: 10.1158/1541-7786.Mcr-17-0598 |
0.634 |
|
| 2018 |
Truong TH, Hu H, Ostrander JH, Lange CA. Abstract A30: PELP1 and AIB1 cooperate to promote breast cancer progression in ER+ breast cancer models Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A30 |
0.645 |
|
| 2018 |
Dwyer AR, Sachdev D, Lange CA. Abstract 949: Progesterone receptor/IRS-1 cooperation promotes stem cell outgrowth and endocrine resistance in estrogen receptor-positive luminal breast cancer Cancer Research. 78: 949-949. DOI: 10.1158/1538-7445.Am2018-949 |
0.638 |
|
| 2017 |
Wang W, Xu ZZ, Costanzo M, Boone C, Lange CA, Myers CL. Pathway-based discovery of genetic interactions in breast cancer. Plos Genetics. 13: e1006973. PMID 28957314 DOI: 10.1371/Journal.Pgen.1006973 |
0.466 |
|
| 2017 |
Leehy KA, Truong TH, Mauro LJ, Lange CA. Progesterone Receptors (PR) Mediate STAT Actions: PR and Prolactin Receptor Signaling Crosstalk in Breast Cancer Models. The Journal of Steroid Biochemistry and Molecular Biology. PMID 28442393 DOI: 10.1016/J.Jsbmb.2017.04.011 |
0.638 |
|
| 2017 |
Knutson TP, Truong TH, Ma S, Brady NJ, Sullivan ME, Raj G, Schwertfeger KL, Lange CA. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs. Journal of Hematology & Oncology. 10: 89. PMID 28412963 DOI: 10.1186/S13045-017-0462-7 |
0.832 |
|
| 2017 |
Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Lange CA, Furcht LT, Laing LG. Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells. Bmc Cancer. 17: 199. PMID 28302091 DOI: 10.1186/S12885-017-3181-0 |
0.579 |
|
| 2017 |
Lange CA. Editorial: Towards Improving the Science of Hormones and Cancer. Hormones & Cancer. PMID 28120150 DOI: 10.1007/S12672-016-0281-2 |
0.414 |
|
| 2017 |
Truong TH, Ostrander JH, Lange CA. Abstract 3618: PELP1 cytoplasmic mislocalization favors estrogen-induced signaling via AIB1 in ER+ breast cancer models Endocrinology. 77: 3618-3618. DOI: 10.1158/1538-7445.Am2017-3618 |
0.579 |
|
| 2017 |
Perez CJS, Anderson TR, Lange CA. Abstract 1331: TGFβ1 induces breast tumor kinase overexpression in triple negative breast cancer via p38 MAPK signaling to glucocorticoid receptors Cancer Research. 77: 1331-1331. DOI: 10.1158/1538-7445.Am2017-1331 |
0.69 |
|
| 2016 |
Bonneterre J, Bosq J, Jamme P, Valent A, Gilles EM, Zukiwski AA, Fuqua SA, Lange CA, O'Shaughnessy J. Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort. Esmo Open. 1: e000072. PMID 27843626 DOI: 10.1136/esmoopen-2016-000072 |
0.521 |
|
| 2016 |
Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Furcht LT, Lange CA, Hurvitz SA, Laing LG. A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity. Oncotarget. PMID 27713176 DOI: 10.18632/Oncotarget.12480 |
0.616 |
|
| 2016 |
Diep CH, Ahrendt H, Lange CA. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes. Steroids. PMID 27641443 DOI: 10.1016/J.Steroids.2016.09.004 |
0.604 |
|
| 2016 |
Leehy KA, Regan Anderson TM, Daniel A, Lange C, Ostrander J. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer. Journal of Molecular Endocrinology. PMID 26831511 DOI: 10.1530/Jme-15-0322 |
0.651 |
|
| 2016 |
Regan Anderson TM, Ma SH, Raj GV, Cidlowski JA, Helle TM, Knutson TP, Krutilina R, Seagroves TN, Lange CA. Breast Tumor Kinase (Brk/PTK6) is Induced by HIF, Glucocorticoid Receptor and PELP1 Mediated Stress Signaling in Triple-Negative Breast Cancer. Cancer Research. PMID 26825173 DOI: 10.1158/0008-5472.Can-15-2510 |
0.798 |
|
| 2016 |
Diep CH, Knutson TP, Mauro LJ, Lange CA. Abstract A39: FOXO1 is a key determinant of progesterone receptor isoform-specific senescence programming in ovarian cancer cells. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A39 |
0.814 |
|
| 2016 |
Anderson TMR, Ma S, Raj GV, Lange CA. Abstract A56: Regulation of breast tumor kinase (Brk) expression in triple-negative breast cancer integrates cellular (HIF-2alpha) and hormonal (cortisol) stress signaling Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-A56 |
0.647 |
|
| 2015 |
Diep CH, Knutson TP, Lange CA. Active FOXO1 is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Molecular Cancer Research : McR. PMID 26577046 DOI: 10.1158/1541-7786.Mcr-15-0431 |
0.809 |
|
| 2015 |
Ravindranathan P, Lange CA, Raj GV. Minireview: Deciphering the Cellular Functions of PELP1. Molecular Endocrinology (Baltimore, Md.). 29: 1222-9. PMID 26158753 DOI: 10.1210/Me.2015-1049 |
0.476 |
|
| 2015 |
Lange CA. A bright future for Hormones and Cancer: farewell comments of Dr. Carol A. Lange, recent past Editor-in-Chief. Hormones & Cancer. 6: 5-6. PMID 25588986 DOI: 10.1007/S12672-014-0212-Z |
0.436 |
|
| 2015 |
Diep CH, Daniel AR, Mauro LJ, Knutson TP, Lange CA. Progesterone action in breast, uterine, and ovarian cancers. Journal of Molecular Endocrinology. 54: R31-53. PMID 25587053 DOI: 10.1530/Jme-14-0252 |
0.813 |
|
| 2015 |
Bravo ML, Pinto MP, Gonzalez I, Oliva B, Kato S, Cuello MA, Lange CA, Owen GI. Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine. 48: 309-20. PMID 24853881 DOI: 10.1007/S12020-014-0288-9 |
0.571 |
|
| 2015 |
Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, D'Assoro AB, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA. Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene. 34: 506-15. PMID 24469035 DOI: 10.1038/Onc.2013.579 |
0.831 |
|
| 2015 |
Diep CH, Lange CA. Abstract POSTER-BIOL-1311: Mechanisms of differential activities of progesterone receptor (PR) isoforms in ovarian cancer models Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1311 |
0.648 |
|
| 2015 |
Hagan CR, Knutson TP, Lange CA. Abstract 1868A: Progesterone receptor promotes inflammatory gene programs in breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-1868A |
0.819 |
|
| 2014 |
Opyrchal M, Salisbury JL, Zhang S, McCubrey J, Hawse J, Goetz MP, Lomberk GA, Haddad T, Degnim A, Lange C, Ingle JN, Galanis E, D'Assoro AB. Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells. Plos One. 9: e96995. PMID 24816249 DOI: 10.1371/Journal.Pone.0096995 |
0.65 |
|
| 2014 |
Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 28: 442-57. PMID 24606123 DOI: 10.1210/Me.2013-1196 |
0.807 |
|
| 2014 |
Hagan CR, Lange CA. Molecular determinants of context-dependent progesterone receptor action in breast cancer. Bmc Medicine. 12: 32. PMID 24552158 DOI: 10.1186/1741-7015-12-32 |
0.617 |
|
| 2014 |
Knutson TP, Lange CA. Tracking progesterone receptor-mediated actions in breast cancer. Pharmacology & Therapeutics. 142: 114-25. PMID 24291072 DOI: 10.1016/J.Pharmthera.2013.11.010 |
0.839 |
|
| 2014 |
Girard BJ, Daniel AR, Lange CA, Ostrander JH. PELP1: a review of PELP1 interactions, signaling, and biology. Molecular and Cellular Endocrinology. 382: 642-51. PMID 23933151 DOI: 10.1016/J.Mce.2013.07.031 |
0.462 |
|
| 2014 |
Opyrchal M, Salisbury JL, Zhang S, McCubrey J, Hawse J, Goetz MP, Haddad TC, Degnim AC, Lange CA, Ingle JN, Galanis E, D'Assoro A. Aurora-A mitotic kinase and induction of endocrine resistance through downregulation of erα expression in initially erα+ breast cancer cells. Journal of Clinical Oncology. 32: 2568-2568. DOI: 10.1200/Jco.2014.32.15_Suppl.2568 |
0.587 |
|
| 2014 |
Diep CH, Lange CA. Abstract 4752: Targeting senescence-induced pro-survival pathways in PR+ ovarian cancer cells Cancer Research. 74: 4752-4752. DOI: 10.1158/1538-7445.Am2014-4752 |
0.595 |
|
| 2014 |
Leehy KA, Anderson TMR, Daniel AR, D'Assoro AB, Lange CA. Abstract 2107: Aurora A kinase and progesterone receptor cross talk in breast cancer Cancer Research. 74: 2107-2107. DOI: 10.1158/1538-7445.Am2014-2107 |
0.714 |
|
| 2014 |
Anderson TMR, Daniel AR, Lange CA. Abstract 2100: Regulation of breast tumor kinase (Brk) expression in triple negative breast cancer integrates cell stress and cortisol signaling pathways Cancer Research. 74: 2100-2100. DOI: 10.1158/1538-7445.Am2014-2100 |
0.661 |
|
| 2014 |
Lange CA. Hormones and Cancer is Alive and Well at ICE/ENDO 2014 Hormones and Cancer. 5: 125-126. DOI: 10.1007/S12672-014-0178-X |
0.351 |
|
| 2013 |
Regan Anderson TM, Peacock DL, Daniel AR, Hubbard GK, Lofgren KA, Girard BJ, Schörg A, Hoogewijs D, Wenger RH, Seagroves TN, Lange CA. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression. Cancer Research. 73: 5810-20. PMID 23928995 DOI: 10.1158/0008-5472.Can-13-0523 |
0.79 |
|
| 2013 |
Hagan CR, Knutson TP, Lange CA. A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research. 41: 8926-42. PMID 23921636 DOI: 10.1093/Nar/Gkt706 |
0.779 |
|
| 2013 |
Knutson TP, Lange CA. Dynamic regulation of steroid hormone receptor transcriptional activity by reversible SUMOylation. Vitamins and Hormones. 93: 227-61. PMID 23810010 DOI: 10.1016/B978-0-12-416673-8.00008-3 |
0.722 |
|
| 2013 |
Diep CH, Charles NJ, Gilks CB, Kalloger SE, Argenta PA, Lange CA. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. Cell Cycle (Georgetown, Tex.). 12: 1433-49. PMID 23574718 DOI: 10.4161/Cc.24550 |
0.835 |
|
| 2013 |
Zukiwski AA, Caillaud J, Bosq J, Fuqua SAW, Lange CA, O'Shaughnessy J, Gilles EM, Bonneterre J. Independent characterization by duel staining of progesterone receptor (PR) and estrogen receptor (ER) in breast cancer (BC). Journal of Clinical Oncology. 31: 596-596. DOI: 10.1200/Jco.2013.31.15_Suppl.596 |
0.475 |
|
| 2013 |
Bosq J, Caillaud J, Lange CA, Fuqua SAW, O'Shaughnessy J, Gilles EM, Zukiwski AA, Bonneterre J. Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC). Journal of Clinical Oncology. 31: 593-593. DOI: 10.1200/Jco.2013.31.15_Suppl.593 |
0.452 |
|
| 2013 |
Seagroves TN, Lange CA. Abstract B077: Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia/HIF-associated breast cancer progression Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-B077 |
0.594 |
|
| 2013 |
Diep CH, Charles NJ, Gilks CB, Kalloger SE, Argenta PA, Lange CA. Abstract 4050: Progesterone receptor signaling induces cellular senescence in ovarian cancer cells. Cancer Research. 73: 4050-4050. DOI: 10.1158/1538-7445.Am2013-4050 |
0.84 |
|
| 2013 |
Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, Yee D, Lange CA. Abstract 3572: Unliganded progesterone receptors augment estrogen-induced growth of breast cancer cells via co-regulation of estrogen receptor target genes. Cancer Research. 73: 3572-3572. DOI: 10.1158/1538-7445.Am2013-3572 |
0.83 |
|
| 2013 |
Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA. Abstract 3569: Phosphorylated and SUMO-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Cancer Research. 73: 3569-3569. DOI: 10.1158/1538-7445.Am2013-3569 |
0.848 |
|
| 2013 |
Anderson TR, Hubbard G, Daniel AR, Peacock D, Wenger RH, Schörg A, Hoogewijs D, Woude GV, Seagroves TN, Lange CA. Abstract 2927: Breast tumor kinase (Brk/PTK6) mediates hypoxia/HIF-1α-associated breast cancer progression. Cancer Research. 73: 2927-2927. DOI: 10.1158/1538-7445.Am2013-2927 |
0.617 |
|
| 2013 |
Hagan CR, Lange CA. Abstract 1073: A common docking (CD) domain in progesterone receptor-B links rapid signaling events to STAT5-dependent gene expression required for breast cancer cell proliferation. Cancer Research. 73: 1073-1073. DOI: 10.1158/1538-7445.Am2013-1073 |
0.65 |
|
| 2013 |
Lange CA, Hankinson SE, Tilley WD. Updates from the Editors Hormones and Cancer. 4: 121-122. DOI: 10.1007/S12672-013-0144-Z |
0.376 |
|
| 2012 |
Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Research : Bcr. 14: R95. PMID 22697792 DOI: 10.1186/Bcr3211 |
0.834 |
|
| 2012 |
Diaz J, Aranda E, Henriquez S, Quezada M, Espinoza E, Bravo ML, Oliva B, Lange S, Villalon M, Jones M, Brosens JJ, Kato S, Cuello MA, Knutson TP, Lange CA, et al. Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1. The Journal of Endocrinology. 214: 165-75. PMID 22593082 DOI: 10.1530/Joe-11-0310 |
0.835 |
|
| 2012 |
Locatelli A, Lofgren KA, Daniel AR, Castro NE, Lange CA. Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression. Hormones & Cancer. 3: 14-25. PMID 22124844 DOI: 10.1007/S12672-011-0097-Z |
0.831 |
|
| 2012 |
Hagan CR, Daniel AR, Dressing GE, Lange CA. Role of phosphorylation in progesterone receptor signaling and specificity. Molecular and Cellular Endocrinology. 357: 43-9. PMID 21945472 DOI: 10.1016/J.Mce.2011.09.017 |
0.669 |
|
| 2012 |
Bonneterre J, Bosq J, Lange C, Gilles E. Abstract P1-07-11: Characterization of progesterone receptor biomarker for predicting antiprogestin activity in human cancers. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-07-11 |
0.453 |
|
| 2012 |
Lange CA. Hormones and Cancer: a Bright Future Hormones and Cancer. 3: 1-2. DOI: 10.1007/S12672-011-0101-7 |
0.443 |
|
| 2011 |
Lofgren KA, Ostrander JH, Housa D, Hubbard GK, Locatelli A, Bliss RL, Schwertfeger KL, Lange CA. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Breast Cancer Research : Bcr. 13: R89. PMID 21923922 DOI: 10.1186/Bcr2946 |
0.806 |
|
| 2011 |
Daniel AR, Hagan CR, Lange CA. Progesterone receptor action: defining a role in breast cancer. Expert Review of Endocrinology & Metabolism. 6: 359-369. PMID 21857868 DOI: 10.1586/Eem.11.25 |
0.604 |
|
| 2011 |
Lange CA, Yee D. Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer. Endocrine-Related Cancer. 18: C19-24. PMID 21613412 DOI: 10.1530/Erc-11-0112 |
0.642 |
|
| 2011 |
Hagan CR, Regan TM, Dressing GE, Lange CA. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. Molecular and Cellular Biology. 31: 2439-52. PMID 21518957 DOI: 10.1128/Mcb.01246-10 |
0.673 |
|
| 2011 |
Locatelli A, Lange CA. Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members. The Journal of Biological Chemistry. 286: 21062-72. PMID 21489997 DOI: 10.1074/Jbc.M110.211409 |
0.599 |
|
| 2011 |
Dressing GE, Goldberg JE, Charles NJ, Schwertfeger KL, Lange CA. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids. 76: 11-7. PMID 20869977 DOI: 10.1016/J.Steroids.2010.09.006 |
0.816 |
|
| 2011 |
Knutson TP, Daniel AR, Lange CA. Abstract 3102: Phosphorylated and SUMO-deficient progesterone receptors transcriptionally up-regulate growth factor signaling pathway genes in breast cancer cells Cancer Research. 71: 3102-3102. DOI: 10.1158/1538-7445.Am2011-3102 |
0.854 |
|
| 2011 |
Hagan CR, Regan T, Dressing G, Lange C. Abstract 2298: ck2-Dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B-isoform-specific target gene expression in breast cancer cells Cancer Research. 71: 2298-2298. DOI: 10.1158/1538-7445.Am2011-2298 |
0.69 |
|
| 2010 |
Charles NJ, Thomas P, Lange CA. Expression of Membrane Progesterone Receptors (mPR/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events Hormones and Cancer. 1: 167-176. PMID 21761364 DOI: 10.1007/S12672-010-0023-9 |
0.854 |
|
| 2010 |
Quezada M, Diaz J, Henriquez S, Bravo ML, Aranda E, Oliva B, Villalon M, Kato S, Cuello MA, Brosens JJ, Lange CA, Owen GI. 2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells. Hormones & Cancer. 1: 117-26. PMID 21761355 DOI: 10.1007/S12672-010-0019-5 |
0.69 |
|
| 2010 |
Daniel AR, Gaviglio AL, Czaplicki LM, Hillard CJ, Housa D, Lange CA. The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Molecular Endocrinology (Baltimore, Md.). 24: 2126-38. PMID 20861224 DOI: 10.1210/Me.2010-0170 |
0.453 |
|
| 2010 |
Ostrander JH, Daniel AR, Lange CA. Brk/PTK6 signaling in normal and cancer cell models. Current Opinion in Pharmacology. 10: 662-9. PMID 20832360 DOI: 10.1016/J.Coph.2010.08.007 |
0.619 |
|
| 2010 |
Castro NE, Lange CA. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Breast Cancer Research : Bcr. 12: R60. PMID 20687930 DOI: 10.1186/Bcr2622 |
0.858 |
|
| 2010 |
Tetel MJ, Lange CA. Molecular genomics of progestin actions Hormones, Brain and Behavior Online. 1439-1466. DOI: 10.1016/B978-008088783-8.00044-9 |
0.557 |
|
| 2009 |
Daniel AR, Lange CA. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 14287-92. PMID 19706513 DOI: 10.1073/Pnas.0905118106 |
0.68 |
|
| 2009 |
Daniel AR, Knutson TP, Lange CA. Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Molecular and Cellular Endocrinology. 308: 47-52. PMID 19549591 DOI: 10.1016/J.Mce.2009.01.004 |
0.79 |
|
| 2009 |
Dressing GE, Hagan CR, Knutson TP, Daniel AR, Lange CA. Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models. Endocrine-Related Cancer. 16: 351-61. PMID 19357196 DOI: 10.1677/Erc-08-0281 |
0.815 |
|
| 2009 |
Hagan CR, Faivre EJ, Lange CA. Scaffolding actions of membrane-associated progesterone receptors. Steroids. 74: 568-72. PMID 19135465 DOI: 10.1016/J.Steroids.2008.12.004 |
0.821 |
|
| 2009 |
Dressing GE, Lange CA. Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation. Steroids. 74: 573-6. PMID 19118566 DOI: 10.1016/J.Steroids.2008.12.001 |
0.612 |
|
| 2009 |
Carbajal L, Deng J, Dressing GE, Hagan CR, Lange CA, Hammes SR. Meeting review: Extra-nuclear steroid receptors-Integration with multiple signaling pathways. Steroids. 74: 551-4. PMID 19073201 DOI: 10.1016/J.Steroids.2008.11.016 |
0.419 |
|
| 2008 |
Lange CA, Yee D. Progesterone and breast cancer. Women's Health (London, England). 4: 151-62. PMID 19072517 DOI: 10.2217/17455057.4.2.151 |
0.607 |
|
| 2008 |
Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutation Research. 647: 21-9. PMID 18723033 DOI: 10.1016/J.Mrfmmm.2008.07.010 |
0.401 |
|
| 2008 |
Lange CA, Sartorius CA, Abdel-Hafiz H, Spillman MA, Horwitz KB, Jacobsen BM. Progesterone receptor action: translating studies in breast cancer models to clinical insights. Advances in Experimental Medicine and Biology. 630: 94-111. PMID 18637487 DOI: 10.1007/978-0-387-78818-0_7 |
0.692 |
|
| 2008 |
Lange CA. Challenges to defining a role for progesterone in breast cancer. Steroids. 73: 914-21. PMID 18243264 DOI: 10.1016/J.Steroids.2007.12.023 |
0.617 |
|
| 2008 |
Faivre EJ, Daniel AR, Hillard CJ, Lange CA. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Molecular Endocrinology (Baltimore, Md.). 22: 823-37. PMID 18202149 DOI: 10.1210/Me.2007-0437 |
0.855 |
|
| 2008 |
Lange CA. Integration of progesterone receptor action with rapid signaling events in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology. 108: 203-12. PMID 17964138 DOI: 10.1016/J.Jsbmb.2007.09.019 |
0.677 |
|
| 2007 |
Daniel AR, Faivre EJ, Lange CA. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 21: 2890-906. PMID 17717077 DOI: 10.1210/Me.2007-0248 |
0.86 |
|
| 2007 |
Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Research. 67: 4199-209. PMID 17483331 DOI: 10.1158/0008-5472.Can-06-3409 |
0.82 |
|
| 2007 |
Lange CA. Editorial: membrane and nuclear steroid hormone receptors: two integrated arms of the same signaling pathway? Steroids. 72: 105-6. PMID 17229446 DOI: 10.1016/J.Steroids.2006.11.021 |
0.398 |
|
| 2007 |
Daniel AR, Qiu M, Faivre EJ, Ostrander JH, Skildum A, Lange CA. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids. 72: 188-201. PMID 17173941 DOI: 10.1016/J.Steroids.2006.11.009 |
0.856 |
|
| 2007 |
Faivre EJ, Lange CA. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Molecular and Cellular Biology. 27: 466-80. PMID 17074804 DOI: 10.1128/Mcb.01539-06 |
0.84 |
|
| 2007 |
Lange CA, Gioeli D, Hammes SR, Marker PC. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annual Review of Physiology. 69: 171-99. PMID 17037979 DOI: 10.1146/Annurev.Physiol.69.031905.160319 |
0.614 |
|
| 2006 |
Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X, Yee D. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. British Journal of Cancer. 95: 1220-8. PMID 17043687 DOI: 10.1038/Sj.Bjc.6603354 |
0.513 |
|
| 2006 |
Lange CA. Review of: Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity Breast Cancer Online. 9. DOI: 10.1017/S1470903106004834 |
0.428 |
|
| 2005 |
Leslie KK, Lange CA. Breast cancer and pregnancy. Obstetrics and Gynecology Clinics of North America. 32: 547-58. PMID 16310671 DOI: 10.1016/J.Ogc.2005.08.010 |
0.483 |
|
| 2005 |
Faivre E, Skildum A, Pierson-Mullany L, Lange CA. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids. 70: 418-26. PMID 15862825 DOI: 10.1016/J.Steroids.2005.02.012 |
0.865 |
|
| 2005 |
Watson CS, Lange CA. Steadying the boat: integrating mechanisms of membrane and nuclear-steroid-receptor signalling. Embo Reports. 6: 116-9. PMID 15678158 DOI: 10.1038/Sj.Embor.7400336 |
0.471 |
|
| 2005 |
Zhang P, Ostrander JH, Faivre EJ, Olsen A, Fitzsimmons D, Lange CA. Regulated association of protein kinase B/Akt with breast tumor kinase. The Journal of Biological Chemistry. 280: 1982-91. PMID 15539407 DOI: 10.1074/Jbc.M412038200 |
0.832 |
|
| 2005 |
Skildum A, Faivre E, Lange CA. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Molecular Endocrinology (Baltimore, Md.). 19: 327-39. PMID 15486045 DOI: 10.1210/Me.2004-0306 |
0.85 |
|
| 2004 |
Pierson-Mullany LK, Lange CA. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Molecular and Cellular Biology. 24: 10542-57. PMID 15572662 DOI: 10.1128/Mcb.24.24.10542-10557.2004 |
0.6 |
|
| 2004 |
Lange CA. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Molecular Endocrinology (Baltimore, Md.). 18: 269-78. PMID 14563938 DOI: 10.1210/Me.2003-0331 |
0.505 |
|
| 2003 |
Pierson-Mullany LK, Skildum A, Faivre E, Lange CA. Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth. Breast Disease. 18: 21-31. PMID 15687686 DOI: 10.3233/Bd-2003-18104 |
0.861 |
|
| 2003 |
Qiu M, Lange CA. MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. The Journal of Steroid Biochemistry and Molecular Biology. 85: 147-57. PMID 12943699 DOI: 10.1016/S0960-0760(03)00221-8 |
0.659 |
|
| 2003 |
Qiu M, Olsen A, Faivre E, Horwitz KB, Lange CA. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Molecular Endocrinology (Baltimore, Md.). 17: 628-42. PMID 12554776 DOI: 10.1210/Me.2002-0378 |
0.843 |
|
| 2001 |
Shen T, Horwitz KB, Lange CA. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Molecular and Cellular Biology. 21: 6122-31. PMID 11509655 DOI: 10.1128/Mcb.21.18.6122-6131.2001 |
0.683 |
|
| 2000 |
Lange CA, Shen T, Horwitz KB. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proceedings of the National Academy of Sciences of the United States of America. 97: 1032-7. PMID 10655479 DOI: 10.1073/Pnas.97.3.1032 |
0.586 |
|
| 2000 |
Lange C, Shen T, Horwitz K. Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells Breast Cancer Research. 2: 1-2. DOI: 10.1186/Bcr104 |
0.61 |
|
| 1999 |
Lange CA, Richer JK, Horwitz KB. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Molecular Endocrinology (Baltimore, Md.). 13: 829-36. PMID 10379882 DOI: 10.1210/Mend.13.6.0290 |
0.665 |
|
| 1998 |
Richer JK, Lange CA, Manning NG, Owen G, Powell R, Horwitz KB. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. The Journal of Biological Chemistry. 273: 31317-26. PMID 9813040 DOI: 10.1074/Jbc.273.47.31317 |
0.629 |
|
| 1998 |
Lange CA, Richer JK, Shen T, Horwitz KB. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. The Journal of Biological Chemistry. 273: 31308-16. PMID 9813039 DOI: 10.1074/Jbc.273.47.31308 |
0.631 |
|
| 1998 |
Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS, Horwitz KB. Progesterone receptor variants found in breast cells repress transcription by wild-type receptors. Breast Cancer Research and Treatment. 48: 231-41. PMID 9598870 DOI: 10.1023/A:1005941117247 |
0.634 |
|
| 1997 |
Leslie KK, Kumar NS, Richer J, Owen G, Takimoto G, Horwitz KB, Lange C. Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation. Annals of the New York Academy of Sciences. 828: 17-26. PMID 9329820 DOI: 10.1111/J.1749-6632.1997.Tb48520.X |
0.542 |
|
| 1997 |
Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Molecular Endocrinology (Baltimore, Md.). 11: 1593-607. PMID 9328342 DOI: 10.1210/Mend.11.11.0006 |
0.585 |
|
| Show low-probability matches. |